7:00 – 8:15 AM |
Sunrise CME Symposium Challenging the Status-Quo: Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond--Expert Debate and Discussions Chair: George L. Bakris, MD Faculty: Robert H. Eckel, MD; Stephen D. Wiviott, MD, FACC Supported by an educational grant from AstraZeneca. |
SESSION I: OBESITY AND LIFESTYLE MEDICINE |
|
8:20 – 8:25 AM |
Chair Introduction and Opening Remarks |
8:25 – 8:45 AM |
Exercise: A Practical Approach |
8:45 – 9:05 AM |
Challenges and Advances in Obesity Pharmacotherapy |
9:05 – 9:25 AM |
The Spectrum of NAFLD and NASH: What the Primary Care Clinician, Endocrinologist, and Cardiologist Should Know |
9:25 – 9:55 AM |
Keynote |
9:55 – 10:25 AM |
Virtual Exhibit Hall Break |
10:25 – 10:30 AM |
Introduction: Expert Debates in Nutrition |
10:30 – 11:10 AM |
Part I: Digging Through Nutritional Controversies in Cardiometabolic Health Monica Aggarwal, MD, FACC; Ronald M. Krauss, MD; Alice H. Lichtenstein, D.Sc. |
11:10 – 11:30 AM |
Part II: Panel Discussion and Q&A Chair: Robert H. Eckel, MD Panelists: Monica Aggarwal, MD, FACC; Ronald M. Krauss, MD; Alice H. Lichtenstein, D.Sc. |
11:30 AM |
Closing Remarks |
11:30 - 11:45 AM |
Refresh and Recharge |
11:45 AM – 12:45 PM |
Virtual PME Symposium (NON–CME) The Continuum of Heart Failure Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA. |
12:45 - 1:00 PM |
Active Stretch Session with NASM-Certified Fitness Instructor: Aria Aloi |
SESSION II: DIABETES MANAGEMENT |
|
1:00 – 1:05 PM |
Chair Introduction |
1:05 – 1:30 PM |
Metabolic Surgery: Beyond Weight Control– Its Role in Diabetes Remission |
1:30 –1:55 PM |
Prediabetes: How Can We Delay the Progression to Diabetes – Implications for Frontline Clinicians |
1:55 – 2:20 PM |
Type 2 Diabetes in Children and Young Adults – Lessons from the RISE Studies |
2:20 – 2:50 PM |
Type 2 Diabetes Management When Cost and Access Are an Issue: a 2020 Update |
2:50 – 3:20 PM |
Virtual Exhibit Hall Break |
3:20 – 3:40 PM |
Intensive Glucose Control for T2DM: A 2020 Update |
3:40 – 4:10 PM |
Translating Evidence to Practice Debate: Which comes first, GLP–1 RAs or SGLT–2 Inhibitors in Patients with T2D and Cardiovascular Disease? Vanita Aroda, MD;Tracy Y. Wang, MD |
4:10 – 4:45 PM |
Expert Panel Discussion and Q&A Chair: Anne L. Peters, MD Panelists: Vanita Aroda, MD; Robert H. Eckel, MD; Steven E. Kahn, MB, ChB; Leigh Perreault, MD; Athena Philis-Tsimikas, MD; Robert E. Ratner, MD; Tracy Y. Wang, MD |
4:45 PM |
Closing Remarks |
7:00 – 8:15 AM |
Sunrise CME Symposium The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches Chair: Christie M. Ballantyne, MD Supported by an educational grant from Esperion Therapeutics, Inc |
SESSION III: KIDNEY DISEASE/HEART FAILURE/HYPERTENSION |
|
8:15 – 8:20 AM |
Chair Introduction |
8:20 – 9:00 AM |
Resistant Hypertension: Diagnosis and Management |
9:00 – 9:40 AM |
Challenging Cases/Issues in Hypertension |
9:40 – 10:10 AM |
Virtual Exhibit Hall Break |
10:10 – 10:40 AM |
Advances in the Prevention and Treatment of HF |
10:40 – 11:10 AM |
Improving Renal Outcomes with SGLT–2 Inhibitors and GLP–1 RAs |
11:10 – 11:35 AM |
Expert Panel Discussion and Q&A Moderator: George L. Bakris, MD Panelists: John Flack, MD; Raymond R. Townsend, MD; Michael A. Weber, MD; Clyde W. Yancy, MD, MSc, MACP |
11:35 - 11:50 AM |
Refresh and Recharge |
11:50 AM – 12:50 PM |
Virtual PME Symposium (NON–CME) VASCEPA® (icosapent ethyl): Elevating the Standard of Care John Canto, MD, MSPH Sponsored by Amarin Pharma, Inc. |
12:50 - 1:05 PM |
Active Stretch Session with NASM-Certified Fitness Instructor: Aria Aloi |
SESSION IV: DYSLIPIDEMIA/ATHEROSCLEROSIS/THROMBOSIS |
|
1:05 – 1:10 PM |
Chair Introduction |
1:10 – 1:40 PM |
Individualizing Lipid Therapy: From Evidence to Practice |
1:40 – 2:00 PM |
Statin Drug–Drug Interactions in Cardiovascular Patients: An Underappreciated Issue |
2:00 – 2:30 PM |
Update on Secondary CHD Prevention Beyond LDL-C: TGs, Lp(a), and Inflammation |
2:30 – 3:00 PM |
Virtual Exhibit Hall Break |
3:00 – 3:30 PM |
Opportunities for ASCVD Prevention and Treatment in Individuals of South Asian Ancestry |
3:30 – 4:10 PM |
Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient Supported by an educational grant from AstraZeneca. |
4:10 – 4:30 PM |
Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Roxana Mehran, MD; Pam R. Taub, MD; Salim S. Virani, MD, PhD, FACC, FAHA; Barbara S. Wiggins, PharmD, FACC |
4:30 PM |
Meeting Closing Remarks |
7:25 – 7:30 AM |
Introduction and Opening Remarks |
7:30 – 8:00 AM |
Cardiometabolic Medicine Subspecialty: The Future is Now. |
8:00 – 8:30 AM |
How Much Prevention Can a Patient Take? |
8:30 – 9:00 AM |
Complexities of CVD Prevention and Care in Women |
9:00 – 11:00 AM |
Tackling the Complexity of Cardiometabolic Care: Challenging Patient Cases & Interactive Panel Discussion Chair: Robert H. Eckel, MD Panelists: George L. Bakris, MD; Christie M. Ballantyne, MD; Martha Gulati, MD; Pamela B. Morris, MD; Anne L. Peters, MD |
11:00 – 11:05 AM |
Closing Remarks |